Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: RECEPTORS, ESTROGEN - METABOLISM , . Treffer: 33

2017

Lax, SF Pathology of Endometrial Carcinoma.
Adv Exp Med Biol. 2017; 943(4):75-96
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Schochter, F; Friedl, TWP; de Gregorio, N; Andergassen, U; Alunni-Fabbroni, M; Trapp, E; Jaeger, B; Heinrich, G; Camara, O; Decker, T; Ober, A; Mahner, S; Fehm, TN; Pantel, K; Fasching, PA; Schneeweiss, A; Janni, W; Rack, BK; SUCCESS Study Group Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer. 2017; 17(4):279-285
Web of Science PubMed FullText FullText_MUG

 

2016

Rasoulzadeh, Z; Ghods, R; Kazemi, T; Mirzadegan, E; Ghaffari-Tabrizi-Wizsy, N; Rezania, S; Kazemnejad, S; Arefi, S; Ghasemi, J; Vafaei, S; Mahmoudi, AR; Zarnani, AH Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells.
PLoS One. 2016; 11(4):e0153684-e0153684 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Bollen, L; Wibmer, C; Wang, M; van der Linden, YM; Leithner, A; Bünger, CE; Jensen, AB; Fiocco, M; Bratschitsch, G; Pondaag, W; Bovée, JV; Dijkstra, PD Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases.
Clin Exp Metastasis. 2015; 32(1):1-5
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF; Austrian Breast and Colorectal Cancer Study Group Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
LANCET. 2015; 386(9992): 433-443.
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol. 2015; 26(8):1685-1691 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Puzovic, V; Brcic, I; Ranogajec, I; Jakic-Razumovic, J Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.
Neoplasma. 2014; 61(4): 439-446. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Winder, T; Giamas, G; Wilson, PM; Zhang, W; Yang, D; Bohanes, P; Ning, Y; Gerger, A; Stebbing, J; Lenz, HJ Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.
Pharmacogenomics J. 2014; 14(1):28-34
Web of Science PubMed FullText FullText_MUG

 

2013

Dubsky, P; Filipits, M; Jakesz, R; Rudas, M; Singer, CF; Greil, R; Dietze, O; Luisser, I; Klug, E; Sedivy, R; Bachner, M; Mayr, D; Schmidt, M; Gehrmann, MC; Petry, C; Weber, KE; Kronenwett, R; Brase, JC; Gnant, M; Austrian Breast and Colorectal Cancer Study Group (ABCSG). EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
Ann Oncol. 2013; 24(3):640-647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Garcia, MM; Guéant-Rodriguez, RM; Pooya, S; Brachet, P; Alberto, JM; Jeannesson, E; Maskali, F; Gueguen, N; Marie, PY; Lacolley, P; Herrmann, M; Juillière, Y; Malthiery, Y; Guéant, JL Methyl donor deficiency induces cardiomyopathy through altered methylation/acetylation of PGC-1α by PRMT1 and SIRT1.
J Pathol. 2011; 225(3):324-335
Web of Science PubMed FullText FullText_MUG

 

Peintinger, F Clinical use of nomograms for breast cancer.
J Surg Oncol. 2011; 103(8): 745-745.
Web of Science PubMed FullText FullText_MUG

 

2010

Pristauz, G; Petru, E; Stacher, E; Geigl, JB; Schwarzbraun, T; Tsybrovskyy, O; Winter, R; Moinfar, F Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.
Histopathology. 2010; 57(6):877-884
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2009

Gonzalez-Angulo, AM; Litton, JK; Broglio, KR; Meric-Bernstam, F; Rakkhit, R; Cardoso, F; Peintinger, F; Hanrahan, EO; Sahin, A; Guray, M; Larsimont, D; Feoli, F; Stranzl, H; Buchholz, TA; Valero, V; Theriault, R; Piccart-Gebhart, M; Ravdin, PM; Berry, DA; Hortobagyi, GN High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
J Clin Oncol. 2009; 27(34):5700-5706 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Houben, R; Ortmann, S; Drasche, A; Troppmair, J; Herold, MJ; Becker, JC Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation.
J Invest Dermatol. 2009; 129(2):406-414 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mönckedieck, V; Sannecke, C; Husen, B; Kumbartski, M; Kimmig, R; Tötsch, M; Winterhager, E; Grümmer, R Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model.
Mol Hum Reprod. 2009; 15(10):633-643 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2008

Mlineritsch, B; Tausch, C; Singer, C; Luschin-Ebengreuth, G; Jakesz, R; Ploner, F; Stierer, M; Melbinger, E; Menzel, C; Urbania, A; Fridrik, M; Steger, G; Wohlmuth, P; Gnant, M; Greil, R; on behalf of the Austrian Breast, Colorectal Cancer Study Group (ABCSG) Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).
Breast Cancer Res Treat. 2008; 112(1): 203-213.
Web of Science PubMed FullText FullText_MUG

 

Peintinger, F; Buzdar, AU; Kuerer, HM; Mejia, JA; Hatzis, C; Gonzalez-Angulo, AM; Pusztai, L; Esteva, FJ; Dawood, SS; Green, MC; Hortobagyi, GN; Symmans, WF Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
Ann Oncol. 2008; 19(12): 2020-2025. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2005

Leibl, S; Moinfar, F Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?
J CLIN PATHOL 2005 58: 700-704. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2004

Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Samonigg, H The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.
CANCER LETT. 2004; 206(1): 59-62.
Web of Science PubMed FullText FullText_MUG

 

Moinfar, F; Regitnig, P; Tabrizi, AD; Denk, H; Tavassoli, FA Expression of androgen receptors in benign and malignant endometrial stromal neoplasms.
VIRCHOWS ARCHIV. 2004; 444(5): 410-414.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Wells, CA; Sloane, JP; Coleman, D; Munt, C; Amendoeira, I; Apostolikas, N; Bellocq, JP; Bianchi, S; Boecker, W; Bussolati, G; Connolly, CE; Dervan, P; Drijkoningen, M; Ellis, IO; Elston, CW; Eusebi, V; Faverly, D; Heikkila, P; Holland, R; Jacquemier, J; Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Reiner A, Saksela E, Sigal-Zafrani B, Sylvan M, Borisch B, Cserni G, Decker T, Kerner H, Kulka J, Regitnig P, Sapino A, Tanous AM, Thorstenson S, Zozaya E Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study.
VIRCHOWS ARCHIV. 2004; 445(2): 119-128.
Web of Science PubMed FullText FullText_MUG

 

2002

Mannweiler, S; Tsybrovskyy, O; Regauer, S The flow cytometric DNA index can predict the presence of lymph node metastases in invasive ductal breast carcinoma.
APMIS. 2002; 110(7-8):580-586
Web of Science PubMed FullText FullText_MUG

 

Regitnig, P; Moser, R; Thalhammer, M; Luschin-Ebengreuth, G; Ploner, F; Papadi, H; Tsybrovskyy, O; Lax, SF Microsatellite analysis of breast carcinoma and corresponding local recurrences.
J Pathol. 2002; 198(2):190-197
Web of Science PubMed FullText FullText_MUG

 

Schindl, M; Schoppmann, SF; Samonigg, H; Hausmaninger, H; Kwasny, W; Gnant, M; Jakesz, R; Kubista, E; Birner, P; Oberhuber, G; Austrian Breast and Colorectal Cancer Study Group Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Clin Cancer Res. 2002; 8(6):1831-1837 [OPEN ACCESS]
Web of Science PubMed FullText

 

2001

Birner, P; Oberhuber, G; Stani, J; Reithofer, C; Samonigg, H; Hausmaninger, H; Kubista, E; Kwasny, W; Kandioler-Eckersberger, D; Gnant, M; Jakesz, R; Austrian Breast & Colorectal Cancer Study Group Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.
Clin Cancer Res. 2001; 7(6):1669-1675 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

Dandachi, N; Hauser-Kronberger, C; Moré, E; Wiesener, B; Hacker, GW; Dietze, O; Wirl, G Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.
J Pathol. 2001; 193(2):181-189
Web of Science PubMed FullText FullText_MUG

 

1999

Jakesz, R; Hausmaninger, H; Haider, K; Kubista, E; Samonigg, H; Gnant, M; Manfreda, D; Tschurtschenthaler, G; Kolb, R; Stierer, M; Fridrik, M; Mlineritsch, B; Steindorfer, P; Mittlböck, M; Steger, G Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
J Clin Oncol. 1999; 17(6):1701-1709 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Sibonga, JD; Dobnig, H; Harden, RM; Turner, RT Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia.
Endocrinology. 1998; 139(9):3736-3742 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Stranzl, A; Schmidt, H; Winkler, R; Kostner, GM Low-density lipoprotein receptor mRNA in human breast cancer cells: influence by PKC modulators.
Breast Cancer Res Treat. 1997; 42(3):195-205
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1996

Chajes, V; Mahon, M; Kostner, GM Influence of LDL oxidation on the proliferation of human breast cancer cells.
Free Radic Biol Med. 1996; 20(1):113-120
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1993

Rosenblum, ER; Stauber, RE; Van Thiel, DH; Campbell, IM; Gavaler, JS Assessment of the estrogenic activity of phytoestrogens isolated from bourbon and beer.
Alcohol Clin Exp Res. 1993; 17(6): 1207-1209.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1991

Stauber, RE; Rosenblum, E; Eagon, PK; Gavaler, JS; Van Thiel, DH The effect of portal-systemic shunting on hepatic sex hormone receptors in male rats.
Gastroenterology. 1991; 100(1):168-174
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Van Thiel, DH; Stauber, RE; Gavaler, JS; Rosenblum, E Evidence for modulation of hepatic mass by estrogens and hepatic feminization.
Hepatology. 1990; 12(3 Pt 1):547-552
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum